【24h】

Study of Controlled Release of PMMA-g-PEG Copolymer and Derivatives Incorporated with the Indomethacin Drug

机译:与吲哚美辛药物的PMMA-G-PEG共聚物和衍生物的控制释放研究

获取原文

摘要

Synthetic polymers are made up of repeated monomeric units, and this gives them a very versatile appearance, making them useful in many areas of science. One is the pharmaceutical, which correlates the properties of the polymer with the active principle, so they can be used as an excipient or in the controlled release system. The PMMA-g-PEG4000 has characteristics derived from its precursors, that are pharmacologically active. When we incorporate drugs into this structure, the polymer can act on the controlled release, lessening the toxic character of the drug and producing fewer side effects. In this work, incorporations of the drug indomethacin were made in the PMMA-g-PEG copolymer and derivatives (PMMA-g-PEG4000 ETIL and PMMA-g-PEG4000 ACET). The samples were characterized by infrared spectroscopy (FTIR), Scanning Electron Microscopy (SEM), thermogravimetric analysis (TGA), and atomic force microscopy (AFM) measurements. For each sample, the controlled release was performed in a total time of 4 h and the efficiency of the modified structures was verified.
机译:合成聚合物由重复的单体单元组成,这使它们具有非常通用的外观,使它们在许多科学领域中有用。一种是药物,其将聚合物的性质与活性原理相关联,因此它们可以用作赋形剂或控制释放系统。 PMMA-G-PEG4000具有源自其前体的特性,即药理学活性。当我们将药物纳入这种结构时,聚合物可以作用于控制释放,减少药物的有毒特征并产生较少的副作用。在这项工作中,在PMMA-G-PEG共聚物和衍生物(PMMA-G-PEG4000 ETIL和PMMA-G-PEG4000 ACET中,制备药物吲哚美辛的掺入。通过红外光谱(FTIR),扫描电子显微镜(SEM),热重分析(TGA)和原子力显微镜(AFM)测量来表征样品。对于每个样品,在4小时的总时间中进行受控释放,验证改性结构的效率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号